相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study
A. V. Marzano et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa
Kristina Navrazhina et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Panagiota S. Filippou et al.
ONCOGENE (2020)
Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach
Lucas Brandao et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Emerging drugs for the treatment of hidradenitis suppurativa
Alecia S. Folkes et al.
EXPERT OPINION ON EMERGING DRUGS (2020)
Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy
Margaret M. Lowe et al.
JCI INSIGHT (2020)
Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa
Laure Guenin-Mace et al.
JCI INSIGHT (2020)
Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/acne inversa
John W. Frew et al.
EXPERIMENTAL DERMATOLOGY (2019)
Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa
Angel S. Byrd et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study
A. R. J. V. Vossen et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Investigational drugs in clinical trials for Hidradenitis Suppurativa
Peter Theut Riis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop
S. Hessam et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature
Lauren K. Hoffman et al.
PLOS ONE (2018)
Interferon-gamma (IFN-) is Elevated in Wound Exudate from Hidradenitis Suppurativa
Anirban Banerjee et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa
D. Jimenez-Gallo et al.
MEDIATORS OF INFLAMMATION (2017)
Brd4 modulates the innate immune response through Mnk2-eIF4E pathway-dependent translational control of IκBα
Yan Bao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model
Kayla F. Goliwas et al.
SCIENTIFIC REPORTS (2017)
Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States
Amit Garg et al.
JAMA DERMATOLOGY (2017)
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013
E. Sbidian et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa
Claire Hotz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Compartmentalized Cytokine Responses in Hidradenitis Suppurativa
Theodora Kanni et al.
PLOS ONE (2015)
Down-Regulation of Nerve Growth Factor Expression in the Bladder by Antisense Oligonucleotides as New Treatment for Overactive Bladder
Mahendra Kashyap et al.
JOURNAL OF UROLOGY (2013)
Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa
Robert Sabat et al.
PLOS ONE (2012)
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)